Melatonin para Trastorno del Sueño por Trabajo por Turnos

References

1. [1] Claudia R C Moreno. Handb Clin Neurol. 2025. Shift work sleep disorder. doi:10.1016/B978-0-323-90918-1.00015-0 PubMed
2. [2] Shujie Wu et al.. ACS Appl Bio Mater. 2025. Melatonin-Loaded Hydrogel Modulates Circadian Rhythms and Alleviates Oxidative Stress and Inflammation to Promote Wound Healing. doi:10.1021/acsabm.4c01752 PubMed
3. [3] Mahide Muge Yilmaz Topcam et al.. Foods. 2025. Exogenous L-Cysteine and Its Transport Through CtaP Play a Role in Biofilm Formation, Swimming Motility, and Swarming Motility of Listeria … doi:10.3390/foods14111845 PubMed
4. [4] Da Young Lee et al.. Diabetes Metab J. 2024. Attention to Innate Circadian Rhythm and the Impact of Its Disruption on Diabetes. doi:10.4093/dmj.2023.0193 PubMed
5. [5] Dou-Dou Li et al.. J Cancer Res Clin Oncol. 2024. Circadian rhythms and breast cancer: from molecular level to therapeutic advancements. doi:10.1007/s00432-024-05917-w PubMed
6. [6] Jiayang Zhang et al.. J Pineal Res. 2024. Circadian light/dark cycle reversal exacerbates the progression of chronic kidney disease in mice. doi:10.1111/jpi.12964 PubMed
7. [7] O Hecmarie Meléndez-Fernández et al.. Int J Mol Sci. 2023. Circadian Rhythms Disrupted by Light at Night and Mistimed Food Intake Alter Hormonal Rhythms and Metabolism. doi:10.3390/ijms24043392 PubMed
8. [8] Shi-Yu Sun et al.. Curr Neuropharmacol. 2022. Treatment of Circadian Rhythm Sleep-Wake Disorders. doi:10.2174/1570159X19666210907122933 PubMed
9. [9] Bárbara Carriedo-Diez et al.. Int J Environ Res Public Health. 2022. The Effects of the Exogenous Melatonin on Shift Work Sleep Disorder in Health Personnel: A Systematic Review. doi:10.3390/ijerph191610199 PubMed
10. [10] Arpita Shah et al.. Metab Syndr Relat Disord. 2022. Is Shift Work Sleep Disorder a Risk Factor for Metabolic Syndrome and Its Components? A Systematic Review of Cross-Sectional Studies. doi:10.1089/met.2021.0070 PubMed
11. [11] Saptadip Samanta. J Environ Pathol Toxicol Oncol. 2022. Melatonin: A Potential Antineoplastic Agent in Breast Cancer. doi:10.1615/JEnvironPatholToxicolOncol.2022041294 PubMed
12. [12] A Gupta et al.. Lett Appl Microbiol. 2022. Culture media, DMSO and efflux affect the antibacterial activity of cisplatin and oxaliplatin. doi:10.1111/lam.13767 PubMed
13. [13] Grant C Glatfelter et al.. Methods Mol Biol. 2022. Methods to Assess Melatonin Receptor-Mediated Phase-Shift and Re-entrainment of Rhythmic Behaviors in Mouse Models. doi:10.1007/978-1-0716-2593-4_39 PubMed
14. [14] Tyler A Steele et al.. Neurotherapeutics. 2021. Circadian Rhythm Sleep-Wake Disorders: a Contemporary Review of Neurobiology, Treatment, and Dysregulation in Neurodegenerative Disease. doi:10.1007/s13311-021-01031-8 PubMed
15. [15] Landon Hester et al.. Chronobiol Int. 2021. Evening wear of blue-blocking glasses for sleep and mood disorders: a systematic review. doi:10.1080/07420528.2021.1930029 PubMed
16. [16] Xiaoli Wu et al.. Front Neurol. 2021. Circadian Rhythm Disorders and Corresponding Functional Brain Abnormalities in Young Female Nurses: A Preliminary Study. doi:10.3389/fneur.2021.664610 PubMed
17. [17] Saptadip Samanta. Crit Rev Oncog. 2021. The Potential Oncostatic Effects of Melatonin against Prostate Cancer. doi:10.1615/CritRevOncog.2021041260 PubMed
18. [18] Derk-Jan Dijk et al.. J Biol Rhythms. 2020. Novel Approaches for Assessing Circadian Rhythmicity in Humans: A Review. doi:10.1177/0748730420940483 PubMed
19. [19] Benjamin Stauch et al.. Nature. 2019. Structural basis of ligand recognition at the human MT1 melatonin receptor. doi:10.1038/s41586-019-1141-3 PubMed
20. [20] Elise R Facer-Childs et al.. Sleep Med. 2019. Resetting the late timing of 'night owls' has a positive impact on mental health and performance. doi:10.1016/j.sleep.2019.05.001 PubMed
21. [21] Nava Zisapel. Br J Pharmacol. 2018. New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. doi:10.1111/bph.14116 PubMed
22. [22] Nanfu Deng et al.. Sex Med Rev. 2018. The Relationship Between Shift Work and Men's Health. doi:10.1016/j.sxmr.2017.11.009 PubMed
23. [23] Renata L Riha. Curr Opin Pulm Med. 2018. The use and misuse of exogenous melatonin in the treatment of sleep disorders. doi:10.1097/MCP.0000000000000522 PubMed
24. [24] Sophie M T Wehrens et al.. Curr Biol. 2017. Meal Timing Regulates the Human Circadian System. doi:10.1016/j.cub.2017.04.059 PubMed
25. [25] Andrew C Forrestel et al.. Diabetologia. 2017. Chronomedicine and type 2 diabetes: shining some light on melatonin. doi:10.1007/s00125-016-4175-1 PubMed
26. [26] Deetje Iggena et al.. J Pineal Res. 2017. Melatonin restores hippocampal neural precursor cell proliferation and prevents cognitive deficits induced by jet lag simulation in adult mice. doi:10.1111/jpi.12397 PubMed
27. [27] Deepa Burman. FP Essent. 2017. Sleep Disorders: Circadian Rhythm Sleep-Wake Disorders. PubMed
28. [28] E Challet. Diabetes Obes Metab. 2015. Keeping circadian time with hormones. doi:10.1111/dom.12516 PubMed
29. [29] Juha Liira et al.. Sao Paulo Med J. 2015. Pharmacological interventions for sleepiness and sleep disturbances caused by shift work. doi:10.1590/1516-3180.20151331T1 PubMed
30. [30] Kathryn J Reid et al.. Sleep Med Clin. 2015. Jet Lag and Shift Work Disorder. doi:10.1016/j.jsmc.2015.08.006 PubMed
31. [31] Anna Wojciechowska et al.. Reprod Biol. 2015. Short-term incubation of bovine placentome sections as a tool to study xenobiotic mechanism of action. doi:10.1016/j.repbio.2015.10.002 PubMed
32. [32] D B Boivin et al.. Pathol Biol (Paris). 2014. Impacts of shift work on sleep and circadian rhythms. doi:10.1016/j.patbio.2014.08.001 PubMed
33. [33] Juha Liira et al.. Cochrane Database Syst Rev. 2014. Pharmacological interventions for sleepiness and sleep disturbances caused by shift work. doi:10.1002/14651858.CD009776.pub2 PubMed
34. [34] Phyllis C Zee et al.. Continuum (Minneap Minn). 2013. Circadian rhythm abnormalities. doi:10.1212/01.CON.0000427209.21177.aa PubMed
35. [35] Benita Middleton. Methods Mol Biol. 2013. Measurement of melatonin and 6-sulphatoxymelatonin. doi:10.1007/978-1-62703-616-0_11 PubMed
36. [36] Kazuo Mishima. Nihon Rinsho. 2013. [Circadian rhythm sleep disorder]. PubMed
37. [37] Andrew D Krystal et al.. J Clin Psychiatry. 2012. Shift work disorder case studies: applying management principles in clinical practice. doi:10.4088/JCP.11073br4 PubMed
38. [38] Bhanu P Kolla et al.. Cleve Clin J Med. 2011. Jet lag and shift work sleep disorders: how to help reset the internal clock. doi:10.3949/ccjm.78a.10083 PubMed
39. [39] Michael Thorpy. Postgrad Med. 2011. Understanding and diagnosing shift work disorder. doi:10.3810/pgm.2011.09.2464 PubMed
40. [40] Eloisa Gitto et al.. J Pineal Res. 2011. Update on the use of melatonin in pediatrics. doi:10.1111/j.1600-079X.2010.00814.x PubMed
41. [41] Emiliano Ricardo Vasconcelos Rios et al.. Int J Neurosci. 2010. Melatonin: pharmacological aspects and clinical trends. doi:10.3109/00207454.2010.492921 PubMed
42. [42] David E McCarty. Nat Sci Sleep. 2010. Ready for takeoff? A critical review of armodafinil and modafinil for the treatment of sleepiness associated with jet lag. doi:10.2147/nss.s6680 PubMed
43. [43] Phyllis C Zee et al.. Curr Treat Options Neurol. 2010. Treatment of shift work disorder and jet lag. doi:10.1007/s11940-010-0090-9 PubMed
44. [44] Michele M Larzelere et al.. Prim Care. 2010. Complementary and alternative medicine usage for behavioral health indications. doi:10.1016/j.pop.2010.02.002 PubMed
45. [45] Ståle Pallesen et al.. Tidsskr Nor Laegeforen. 2009. [Circadian rhythm sleep disorders]. doi:10.4045/tidsskr.08.0226 PubMed
46. [46] Rüdiger Hardeland. Curr Opin Investig Drugs. 2009. Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders. PubMed
47. [47] Seithikurippu R Pandi-Perumal et al.. Nat Clin Pract Neurol. 2008. The roles of melatonin and light in the pathophysiology and treatment of circadian rhythm sleep disorders. doi:10.1038/ncpneuro0847 PubMed
48. [48] Rüdiger Hardeland et al.. Arzneimittelforschung. 2008. Melatonergic drugs in clinical practice. doi:10.1055/s-0031-1296459 PubMed
49. [49] Venkataramanujan Srinivasan et al.. Travel Med Infect Dis. 2008. Jet lag: therapeutic use of melatonin and possible application of melatonin analogs. doi:10.1016/j.tmaid.2007.12.002 PubMed
50. [50] Ana Barion et al.. Sleep Med. 2007. A clinical approach to circadian rhythm sleep disorders. doi:10.1016/j.sleep.2006.11.017 PubMed
51. [51] L C Lack et al.. Cell Mol Life Sci. 2007. Chronobiology of sleep in humans. doi:10.1007/s00018-007-6531-2 PubMed
52. [52] Gary S Richardson et al.. Am J Manag Care. 2007. Circadian rhythmicity and the pharmacologic management of insomnia. PubMed
53. [53] Robert L Sack et al.. Sleep. 2007. Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine … doi:10.1093/sleep/30.11.1460 PubMed
54. [54] Ba X Hoang et al.. Eur J Cancer Prev. 2007. Neurobiological effects of melatonin as related to cancer. doi:10.1097/CEJ.0b013e32801023dc PubMed
55. [55] Timothy I Morgenthaler et al.. Sleep. 2007. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report. doi:10.1093/sleep/30.11.1445 PubMed
56. [56] Jonathan R L Schwartz et al.. Drugs. 2006. Shift work sleep disorder: burden of illness and approaches to management. doi:10.2165/00003495-200666180-00007 PubMed
57. [57] S R Pandi-Perumal et al.. FEBS J. 2006. Melatonin: Nature's most versatile biological signal? doi:10.1111/j.1742-4658.2006.05322.x PubMed
58. [58] Anders Johnsson et al.. Tidsskr Nor Laegeforen. 2006. [Rhythms, depressions and light]. PubMed
59. [59] Gary S Richardson. J Clin Psychiatry. 2005. The human circadian system in normal and disordered sleep. PubMed
60. [60] Yvan Touitou. Bull Acad Natl Med. 2005. [Melatonin: what for?]. PubMed
61. [61] Fred W Turek et al.. Sleep Med. 2004. Melatonin, sleep, and circadian rhythms: rationale for development of specific melatonin agonists. doi:10.1016/j.sleep.2004.07.009 PubMed
62. [62] Y Touitou. Exp Gerontol. 2001. Human aging and melatonin. Clinical relevance. doi:10.1016/s0531-5565(01)00120-6 PubMed
63. [63] N Zisapel. CNS Drugs. 2001. Circadian rhythm sleep disorders: pathophysiology and potential approaches to management. doi:10.2165/00023210-200115040-00005 PubMed
64. [64] G Copinschi et al.. Novartis Found Symp. 2000. Pathophysiology of human circadian rhythms. doi:10.1002/0470870796.ch9 PubMed
65. [65] DR Wagner. Curr Treat Options Neurol. 1999. Circadian Rhythm Sleep Disorders. doi:10.1007/s11940-999-0020-x PubMed
66. [66] D J Skene et al.. Adv Exp Med Biol. 1999. Use of melatonin in the treatment of phase shift and sleep disorders. doi:10.1007/978-1-4615-4709-9_10 PubMed
67. [67] J Arendt. J R Soc Med. 1999. Jet-lag and shift work: (2). Therapeutic use of melatonin. doi:10.1177/014107689909200805 PubMed
68. [68] J Arendt. Rev Reprod. 1998. Melatonin and the pineal gland: influence on mammalian seasonal and circadian physiology. doi:10.1530/ror.0.0030013 PubMed
69. [69] P M Sedgwick. Postgrad Med J. 1998. Disorders of the sleep-wake cycle in adults. doi:10.1136/pgmj.74.869.134 PubMed
70. [70] J Arendt et al.. J Biol Rhythms. 1997. Efficacy of melatonin treatment in jet lag, shift work, and blindness. doi:10.1177/074873049701200616 PubMed
71. [71] V Kumar. Indian J Exp Biol. 1996. Melatonin: a master hormone and a candidate for universal panacea. PubMed
72. [72] M Härmä. Duodecim. 1991. [Shift work, jet lag and sleep]. PubMed